1,064
Participants
Start Date
April 14, 2009
Primary Completion Date
May 31, 2015
Study Completion Date
May 31, 2015
systemic non-biological treatments
as prescribed
anti-TNF biologics
as prescribed
golimumab
as prescribed
non-anti-TNF biologics
as prescribed
general population
non-treated cohort
Lead Sponsor
Janssen Biotech, Inc.
INDUSTRY